Skip to main content

February 2016 Vol 9, No 1

Editorial
The Institute for Clinical and Economic Review and Its Growing Influence on the US Healthcare
Laura T. Pizzi, PharmD, MPH
Read More
Business
The Economics of Medicare Accountable Care Organizations
Erwin A. Blackstone, PhD, Joseph P. Fuhr, Jr, PhD
Stakeholder Perspective
Time to Reexamine Accountable Care Organizations?
by J. Warren Salmon, PhD
Read More
Original Research
Comparison of Treatment Costs for Breast Cancer, by Tumor Stage and Type of Service
Helen Blumen, MD, MBA, Kathryn Fitch, RN, MEd, Vincent Polkus, MSEM, MBA
Stakeholder Perspective
An Ounce of Prevention Is Not a Choice a Patient Gets to Make for Late-Stage Cancer
by Michael Kleinrock
Read More
Clinical
Payer Perspectives on PCSK9 Inhibitors
Stanton R. Mehr
Read More
Industry Trends
Top Healthcare Market Trends in 2016
John Santilli, MBA, F. Randy Vogenberg, PhD, FASHP
Read More
Clinical
Key Features of Academic Detailing: Development of an Expert Consensus Using the Delphi Method
James S Yeh, MD, Thomas J. Van Hoof, MD, EdD, Michael A. Fischer, MD, MS
Stakeholder Perspective
Improving Patient Outcomes and Drug Prescribing Cost-Effectiveness Through Academic Detailing
by Jack E. Fincham, PhD, RPh
Read More

Results 1 - 6 of 6